Access to health care is the best way to protect prisons from COVID-19

On Nelson Mandela International Day, 18 July, WHO/Europe focuses on how prisons can develop and implement effective COVID-19 vaccination policies as part of quality health-care programmes for both inmates and staff. To support countries, WHO has developed a package of new materials for protecting health in prisons, including by ensuring equitable access to vaccines.

100 000 COVID-19 cases in prisons

The COVID-19 pandemic has shown how important it is to guarantee the right to health care in detention facilities. Overcrowded conditions that may be unhygienic and poorly ventilated, together with stressful environments and, in some cases, the poor nutritional status of individuals, can make COVID-19 an even more dangerous disease for people in prison.

During the pandemic, many prisons in the WHO European Region experienced shortages of protective and diagnostic equipment, as well as the most basic commodities to prevent infection, including water and soap. Even when vaccines became available, many prisons did not have the correct equipment to vaccinate all inmates.

In addition, the mobility of prison officers and support staff between detention centres and surrounding communities, coupled with the transfer of prisoners between facilities, increased the risk of the virus entering prison walls and quickly spreading inside before being exported back to the outside community.

According to the most recent available data, more than 100 000 COVID-19 cases have been registered in prisons in the Region since May 2020.

Higher health risks for people in detention

The new WHO/Europe advocacy brief “Why people living and working in detention facilities should be included in national COVID-19 vaccination plans” explains why Member States have the duty to protect all citizens, regardless of their legal condition. The publication presents good examples of COVID-19 vaccination policies.

“Compared to the outside community, people living in prisons have a higher burden of both communicable and noncommunicable diseases. In addition to having a higher risk of contracting COVID-19, the burden makes them more vulnerable to suffering severe health outcomes, including death,” says Dr Carina Ferreira-Borges, Acting Head of the WHO European Office for the Prevention and Control of Noncommunicable Diseases (NCD Office), which produced the new policy brief.

“Therefore, it is crucial that we not only continue to provide health care and vaccination measures in detention facilities, but also improve them for the sake of those who work and live in prisons.”

Vaccination in prisons: WHO recommendations

The WHO policy brief recommends the following measures to tackle the risks of further COVID-19 spread in prisons across the Region.

• People living in prisons should be included in national COVID-19 vaccination plans.
• People living in prisons should have a guaranteed right to be informed about how to protect themselves from COVID-19 with immunization and other public health measures.
• If facility-wide vaccination for everyone is not possible, vulnerable groups in detention settings should be prioritized.
• The prison workforce (health-care workers and prison staff) should be prioritized for vaccination.

“We need to remember that wisely chosen and evidence-based practices in prisons can be a good opportunity to provide health services and products to vulnerable groups of society that may have had very limited access to health care in general ahead of incarceration,” explains Dr Ferreira-Borges.

“It is very important that detention facilities continue all measures to protect people from the virus, but at the same time remain open for health care so no one is left behind – in line with the aim of the WHO European Programme of Work.”

Reliable data from prisons using WHO instruments

Information is key for creating evidence-based policies, so important priorities include the development of a quality health information system for prisons and the inclusion of prison health in public health.

The recently published “WHO COVID-19 prison surveillance protocol” is based on previous surveillance systems for infectious diseases and enriched by the experience of fighting the pandemic across the Region in 2020–2021. The protocol establishes standards of reporting while allowing countries to adapt reporting mechanisms and levels of data disaggregation to local conditions.

With this data, WHO produces country-specific bulletins that allow countries to benchmark their practices and improve policy actions in detention facilities to improve their information systems. Reporting is also linked to an alert-driven system that triggers WHO’s technical support to countries when COVID-19 outbreaks are identified in prisons.

“To monitor the situation in prisons and react to a rapidly changing situation, we need reliable data. It is always a challenge for detention facilities, so we have developed a tool that will help countries and prison authorities to gather and report information that is crucial for addressing the current pandemic,” says Dr Filipa Costa, a health policy specialist working for the alcohol, illicit drugs and prison health programme at the NCD Office.

Varied impact of COVID-19 on routine immunization in the European Region

The WHO European Region saw a 1% decrease in routine immunization coverage, from 95% in 2019 to 94% in 2020 (the third dose of diphtheria-tetanus-pertussis-containing vaccine (DTP3) is used as a tracer indicator), according to WHO/United Nations Children’s Fund (UNICEF) estimates for routine coverage in 2020, released on 15 July 2021.

The Region as a whole continues to achieve high routine immunization coverage, and experienced a smaller decline during 2020 than all other regions of the world. The figures for 2020 are preliminary, based on data reported through the annual WHO/UNICEF Joint Reporting Form by only 36 (68%) of the Member States in the Region. The figures will be revised later in 2021 as more complete data become available.

The relatively small decrease in regional DTP3 coverage reflects intense efforts made by the ministries of health in the Region to continue or catch up on childhood immunizations, despite programmatic restrictions due to response measures for the COVID-19 pandemic.

However, the decrease masks large variations among countries, larger declines in some countries, and a lack of reported data from some countries where COVID-19 disruptions have also affected capacity to collect and report routine immunization coverage data.

Among the 36 European Member States for which estimates are available, a significant (≥ 5%) general drop in routine immunization coverage (across all antigens combined) was reported by Azerbaijan, Bulgaria, Georgia, Kazakhstan, Kyrgyzstan and the Republic of Moldova.

Lesser declines, with values below the regional target of 95% coverage, were reported by Italy (all antigens) and by Denmark, Lithuania and Romania (measles- and rubella-containing vaccines).

A few countries reported a slight increase in coverage for DTP3 and the first dose of measles-containing vaccine (MCV1), with more notable increases reported by Estonia and San Marino. Ukraine reported a decrease in MCV1 coverage but also an increase in DTP1 and DTP3.

Montenegro reported worryingly low coverage for measles, which fell to 24% in 2020 from an already low 33% in 2019. Other countries reported coverage levels comparable to 2019.

Accumulation of unvaccinated children can reverse decline in measles cases

Attaining the optimal immunization coverage (≥ 95%) with 2 measles- and rubella-containing vaccine doses at all subnational levels (provinces, regions and districts) while closing immunity gaps in all age groups is crucial for the elimination of measles and rubella.

While reported measles cases have declined dramatically (from over 104 000 in 2019 to approximately 12 000 in 2020, and only 59 for January to May this year so far), any decrease in vaccination coverage can lead to a rapid accumulation of vulnerable children and potentially fuel large outbreaks in the future.

Moreover, it is likely that factors related to the implementation of national COVID-19 response measures during 2020 contributed to the observed decline in reported measles cases in the Region. These include:

• fewer visits to hospitals and medical practitioners during full or partial lockdowns, which may have led to milder cases of disease going undetected;
• decreased measles and rubella virus transmission as a result of non-pharmaceutical measures such as stay-at-home recommendations, school closures, bans on mass gatherings, international border closures, widespread physical distancing, and improved hand hygiene and coughing/sneezing etiquette; and
• interrupted or disrupted disease surveillance due to the diversion of human and other resources to the COVID-19 response.

Measles continues to be endemic in many countries around the world and will resurge wherever it finds sufficient vulnerable people to infect. It is vital for children’s health that any missed vaccinations, against measles or any other vaccine-preventable disease, be caught up as quickly as possible.

Addressing COVID-19 challenges at the country level

The relatively small changes in coverage reported by many countries in the Region in 2020 are a reflection of the commitment and substantial efforts of national health system to ensure – and assure parents and caregivers – that routine vaccination sessions could continue with appropriate infection prevention control measures at the vaccination points for both parents and health workers.

In the Netherlands, for example, based on preliminary published data, vaccination coverage remained relatively high for nearly all vaccines in 2020, despite a temporary dip in monthly coverage in March 2020. Several initiatives implemented together prevented a major disruption to immunization service delivery in 2020:

• Group/mass vaccination events were converted into personal appointments with parents and children.
• Missed vaccinations were rescheduled in combination with other vaccinations (for example, human papillomavirus with meningitis ACWY).
• All mother-and-child care offices were kept open, with only 1 parent and child allowed to visit at a time.
• Invitations for vaccination included a flyer informing people on the safety of routine vaccination during the COVID-19 pandemic.
• The safety of immunization during the pandemic was also highlighted by the media.

European Immunization Agenda 2030

To tackle the challenges of the next decade, including the impact of COVID-19 on immunization systems and coverage, the Region will initiate a new immunization strategy to be presented to the WHO Regional Committee for Europe in September 2021. The European Immunization Agenda 2030 is a country-led policy framework focused on strengthening immunization systems in order to reduce the burden of vaccine-preventable diseases among all people at all ages.

Global picture

Globally, 23 million children missed out on lifesaving vaccines through routine vaccination services in 2020 – 3.7 million more than in 2019. This is the highest number of unvaccinated children since 2009, taking us back more than a decade. The majority of these children (up to 17 million) did not receive a single vaccine, highlighting immense inequities in vaccine access.

Without high childhood vaccination rates, countries face risks of multiple epidemics. This could be catastrophic in the context of COVID-19, particularly for countries with the weakest health systems.

Colin Kaepernick Publishing New Children’s Books, ‘I Color Myself Different’

‘Deeply negative impact’ of COVID pandemic, reverses SDG progress

New book “GEN Z 360” by Hana Ben-Shabat is a Comprehensive…

GEN Z 360 Helps Leaders, Business Owners, Retail and More Prepare for the Inevitable Change that Gen Z is Bringing to Culture, Work, and Commerce

SUMMIT, N.J. (PRWEB) July 15, 2021

Award Winning Journalist and Author, Alicia Doyle, Featured on ‘I Want To Know Your Story’

LOS ANGELES, CA, UNITED STATES, July 15, 2021 /EINPresswire.com/ — Leslie Grodin, host and producer of I Want To Know Your Story, has featured Alicia Doyle, three-time award-winning author of Fighting Chance, in episode 88 on YouTube.

I Want To Know Your Story is more than a YouTube channel, it is a platform that gives people a place to be heard.

“Everyone deserves to share their story in a space with no judgment,” said Grodin, who believes that everyone’s story is important, and sharing our stories creates a community among strangers, where people can find connection in similarities they have with others.

“Simply hearing that Alicia was in a place where she wants to share her story, most recently writing a book, I was all for sitting down for an interview with her,” Grodin said.

Since Fighting Chance was published in February of 2020 – just one month before the global pandemic hit – it has won three literary awards: First Place in Creative Nonfiction and Memoir in the 2020 North Street Book Prize Winning Writers Competition; 2020 WBAN “Cool Story of the Year”; and 2021 Best Autobiographical Book.

“It was incredible to sit down with Alicia and hear her talk about overcoming traumas from early childhood into her late twenties,” Grodin said. “Amazed by what she heard and experienced while on assignment at a boxing gym, it was clear from her interview that she still never expected boxing to be her salvation.”

“Allowing herself to be open and accept a different perspective about something she had previously passed judgment on fit so in line with why I do these interviews,” Grodin continued. “You just never know….our judgments and assumptions may just get in the way of some of the greatest possible connections and relationships. Alicia’s story is one of strength, empowerment, and ultimately giving back. I am honored to have gotten to spend the time with her in the ring that day, thankfully just for an interview and not a bout.”

In April of 2020, Slavica Bogdanov, a 20-time-awarded Canadian screenwriter and owner of Empowering Entertainment, partnered with Doyle to bring her true story to the Silver Screen.

Bogdanov chose Doyle’s story because “I loved the courage and tenacity, and I was touched by the heart of a fighter who fights for her right to stand up for herself and win at the game of life.”

Doyle, a journalist for more than three decades, discovered boxing at age 28 in the late 1990s when she went on assignment at a boxing gym for at-risk youth. For two years, Doyle simultaneously worked as a newspaper reporter while training and competing as a boxer, making her one of only a few hundred women in America who infiltrated this male-dominated sport. During her boxing career, she won two Golden Gloves championship titles and earned three wins by knockout – and her pro debut at age 30 in the year 2000 was named The California Female Fight of the Year.

Aurora DeRose
Boundless Media Inc.
+1 951-870-0099
email us here

Potential Concerns with NuVasive MAGEC System Implants – FDA Safety Communication

Date Issued: July 15, 2021

The U.S. Food and Drug Administration (FDA) is informing patients, their caregivers, and health care providers of potential mechanical failures and concerns about tissue incompatibility (biocompatibility) associated with components of the following NuVasive Specialized Orthopedics’ MAGEC devices:

• MAGEC Spinal Bracing and Distraction System
• MAGEC 2 Spinal Bracing and Distraction System
• MAGEC System 
• MAGEC System Model X device
• MAGEC System Model X rod
• MAGEC System Rods

In February 2020, NuVasive issued an Urgent Field Safety Notice recalling its MAGEC devices to address a mechanical component failure where the endcap was separating from the rod part of the device. In July 2020, the FDA cleared a modified version of the MAGEC Model X rod, designed to mitigate endcap separation events.

Additional biocompatibility concerns potentially related to the existing endcap failures were raised in December 2020 when NuVasive issued an updated Field Safety Notice intended for customers in the European Union. In addition, the FDA began receiving reports in early 2021 describing local tissue reactions potentially related to endcap separation events with the MAGEC devices.

As NuVasive continues to investigate the root cause of these issues, the FDA is working with the manufacturer to evaluate new biocompatibility testing results and assess whether there is any clinically meaningful impact to patients with MAGEC devices.

Recommendations for Caregivers and Patients Considering a MAGEC Device

• Talk to a doctor about the benefits and risks of the MAGEC device. The FDA believes the benefits of a MAGEC device outweigh the risks for U.S. patients based on the current FDA-cleared indications for use and labeling. Indications for use and labeling may vary in other countries.

Recommendations for Patients Who Have a MAGEC Device and their Caregivers

• At this time, the FDA does not recommend the removal of functioning MAGEC rods prior to the two years after implantation.
• Be aware that if a patient experiences increasing levels of unexpected back pain with a MAGEC device, the health care provider should perform an additional examination of the patient’s back, including obtaining x-rays to evaluate the condition of the MAGEC implant.
• If patients are experiencing a problem with a MAGEC device, the FDA encourages patients and their parents or caregivers to report the problem to their health care provider and to the FDA through the MedWatch Voluntary Reporting Form.

Recommendations for Health Care Providers

• Follow current U.S. labeling instructions.
• Be aware MAGEC devices are:
  • Cleared for implantation for no more than two years.
  • To be implanted only in skeletally immature patients less than 10 years of age with severe progressive spinal deformities associated with or at risk of Thoracic Insufficiency Syndrome (TIS). See current device labeling for the complete Indications for Use Statement.
• Perform a full evaluation, including radiographs, of a patient, presenting with unexplained symptoms of back pain, inflammation, or deformity. 
• Decisions about removing or exchanging a MAGEC device should be made by health care providers in consultation with the patient and their caregivers on a case-by-case basis. Discuss with patients and their caregivers that, at this time, the FDA does not recommend removal (prior to two years post implantation) of asymptomatic MAGEC devices that are stable and well-functioning. 
• Report any adverse events or suspected events experienced with a MAGEC device through MedWatch, the FDA Safety Information and Adverse Event Reporting program.

Device Description

MAGEC is a growing spinal rod system intended for use in children under 10 years of age. MAGEC devices use magnets to help correct spinal deformities as the child grows. They are designed to help avoid multiple operations to correct the spinal curve.

Potential Risks Associated with MAGEC Devices

The FDA is aware of reports describing endcap separation, O-ring seal failure, and of potential exposure of internal components of this device to living tissue that may lead to adverse local tissue reactions.

Endcap Separation

In 2020, NuVasive made changes to the MAGEC device design to address endcap separation problems. The risk associated with endcap separation is unanticipated exposure of patient’s tissue to internal components of the device that have not been completely tested for biocompatibility. In July 2020, the FDA cleared a new version of the MAGEC X rod, and this version of the MAGEC X device (MAGEC 2b) is designed to mitigate endcap separation. The recommendations in this communication apply to all MAGEC devices, including the modified MAGEC Model X rod cleared by the FDA in July 2020.

Biocompatibility

On April 5, 2021, and updated April 9, 2021, NuVasive informed health care providers of biocompatibility testing concerns, and voluntarily placed all MAGEC devices on a global ship hold.

To evaluate whether the components covered by the endcap are biocompatible and to satisfy updated testing standards, NuVasive has been conducting additional biocompatibility testing. The FDA is working with the manufacturer to evaluate the new biocompatibility testing results.

On July 15, 2021, NuVasive posted an updated statement informing U.S. health care providers that the ship hold in the U.S. has been lifted for the MAGEC devices. The FDA believes it is in the best interest of patients to make the modified MAGEC X device available in the U.S. at this time because (1) the overall benefits of the device outweigh the known risks for on-label use in the U.S. compared to alternative treatments, (2) the U.S. indications and instructions for use, which restrict use to patients less than 10 years old and for a two-year implantation time, further mitigate known risks, (3) the modified MAGEC X (MAGEC 2b) device, designed to mitigate endcap separation events and related biocompatibility concerns, will be the only device version currently available for sale in the U.S., and (4) the U.S. labeling has been updated to include a discussion of known risks associated with the device.

FDA Actions

The FDA is working with NuVasive to:

• Evaluate additional biocompatibility testing intended to address specific theoretical biocompatibility concerns with these devices and collect additional data to better understand potential risks to patients. 
• Provide health care providers and patients access to an adequate supply of modified MAGEC devices, which are magnetically distractable growing rods designed to reduce the number of surgeries needed compared to alternatives.
• Ensure patients with a MAGEC implant continue to receive appropriate follow-up monitoring.

The FDA will keep the public informed if significant new information becomes available.

Reporting Problems with a MAGEC Device

The FDA encourages health care providers to report any adverse events or suspected adverse events experienced with NuVasive MAGEC device system implants.

Prompt reporting of adverse events can help the FDA identify and better understand the risks associated with medical devices.

Questions?

If you have questions, email the Division of Industry and Consumer Education (DICE) at DICE@FDA.HHS.GOV or call 800-638-2041 or 301-796-7100.

Every Kid Sports Receives $5M Donation from The DICK’S Sporting Goods Foundation to Keep Kids Playing Youth Sports

BEND, OREGON, UNITED STATES, July 15, 2021 /EINPresswire.com/ — Every Kid Sports (EKS), a national 501(c)(3) non-profit organization, is pleased to announce a charitable contribution in the amount of $5 million from The DICK’S Sporting Goods Foundation, Sports Matter Initiative. The Every Kids Sports mission is to help ensure every kid has a chance to play sports.The contribution allows Every Kids Sports to fund approximately 42,000 kids across the nation in their participation in recreational youth sports. Through the signature program, Every Kid Sports Pass, qualified families could receive up to $150 four times a year, per child, for participation in the sports of their child’s choice. The Every Kid Sports Pass application portal opened on June 22.

“We are thrilled to be partnering with The DICK’S Sporting Goods Foundation to ensure youth sports can restart across the country post-pandemic,” states Executive Director Natalie Hummel. “We are so well aligned with DICK’S Foundation Sports Matter Initiative and believe The DICK’s Sporting Goods Foundation support will help save youth sports and give so many kids the opportunity to experience the joy of playing sports.”

“After a tough year for many kids and families, we are proud to be partnering with Every Kids Sports to provide funding that will cover participation fees,” said Executive Director of the DICK’S Sporting Goods Foundation Aimee Watters. “We believe that sports make people better and are excited to give so many kids the opportunity to play.”

Every Kid Sports encourages sport sampling, as research shows that playing a variety of sports allows for greater physical literacy, better socialization, and greater enjoyment in being physically and emotionally active. It prepares kids for a lifetime of activity, connection, and positive experiences.

###

About Every Kid Sports
Headquartered in Bend, Oregon, Every Kid Sports is a national 501(c)(3), a 2021 GuideStar Platinum Transparency awarded nonprofit organization that has worked since 2009 to provide a variety of sports-related opportunities designed to remove the financial barriers that typically prevent kids from being active through sports. Every Kid Sports has been recognized by The Aspen Institute as a 2019 Project Play Champion, as well as a recipient of the 2019 Beyond Sports Collective Impact Award for Reduced Inequalities. Partners in their work have included Nike, T-Mobile, Little League International and the National Basketball Players Association Foundation.

About The DICK’S Sporting Goods Foundation
The DICK’S Sporting Goods Foundation is a tax-exempt 501(c)(3) non-profit corporation with a mission to inspire and enable sports participation. It was created by DICK’S Sporting Goods, Inc. as a private corporate foundation to support DICK’S charitable and philanthropic activities.

For more information regarding this announcement, please contact:

Wayne Henninger
Wayne Henninger Communications, LLC / Every Kid Sports
wayne@waynehenninger.com

<

p class=”contact c5″ dir=”auto”>Tiffany Cook
Every Kid Sports
+1 210-846-4034
tiffany@everykidsports.org
Visit us on social media:
Facebook
Twitter
LinkedIn

The Apparel Industry Adopts Biological Material And Techniques To Create Eco-Fibers, Which Are In Demand

Segments covered: By Type – Women’s Wear, Men’s Wear, Kids Wear; By Distribution Channel – Retail Stores, Online Stores; By Type of Fiber – Man-Made Fibers, Cotton Fibers, Animal Based Fibers, Vegetable Based Fibers. Subsegments covered: Dresses & Skirts, Women’s Trousers, Blouses, Women’s Jerseys, Sweatshirts & Pullovers, Women’s Coats and Jackets, Women’s Suits & Ensembles, Women’s Blazers, Night & Underwear (Women & Girls), Women’s T shirts & Slarlets, Women’s Sports & Swimwear, Other Women’s Wear, Men’s Trousers, Men’s Shirts, Men’s Jerseys, Sweatshirts & Pullovers, Men’s Coats and Jackets, Men’s Blazers, Men’s Suits, Night & Underwear( Men’s and Boys), Men’s T shirts & Slarlets, Men’s Sports & Swimwear, Other Men’s Wear, Infant And Toddler Clothes, Young Children Clothes

/EIN News/ — LONDON, July 15, 2021 (GLOBE NEWSWIRE) — According to The Business Research Company’s research report on the apparel market, apparel manufacturers are adopting advanced techniques such as enzyme technology, foam technology, and plasma technology for the production of eco-fibers. Eco fibers are the organic materials that are environmentally sustainable.

For instance, Lenzing AG offers Tencel modal fibers using eco soft technology that utilizes an elemental chlorine-free bleaching technique during manufacturing. This technology has a high recovery rate for ingredients and causes very low-rate air emissions.

For example, Mango Materials produces biodegradable bio-polyester that is a sustainable alternative to synthetic polyester. Mango Materials focuses on the production of polyhydroxyalkanoate, a biodegradable polymer from methane. In this process, plastic chips are melted to make plastic bags or fiber for clothing.

Similarly, Nano Textile created cavitation technology that embeds fabric finishes directly into fabrics. Nano fabrics or nano textiles are fabrics engineered with small particles that allows the fabric to have properties such as superhydrophobicity (extreme water resistance), odor and moisture elimination, increased elasticity and strength, and bacterial resistance. Apparel manufacturers should adopt advanced technologies to produce eco-friendly smart textiles, allowing them to be competitive with conventional fashion offerings.

The global apparel market size 2020 was $527.8 billion, and it is expected to grow to $635.7 billion in 2021 at a compound annual growth rate (CAGR) of 20%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The global apparel market worth is expected to reach $842.3 billion in 2025 at a CAGR of 7%.

The Business Research Company’s report titled Apparel Global Market – Opportunities And Strategies – Global Forecast To 2030 covers major apparel companies, apparel market share by company, apparel manufacturers, apparel market size, and apparel market forecasts. The report also covers the global apparel market and its segments.

Request For A Sample Of The Global Apparel Market Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2347&type=smp

Asia Pacific is the largest region in the global apparel market, accounting for 32.8% of the total in 2020. It was followed by Western Europe, North America, and then the other regions. Going forward, the fastest-growing regions in the apparel market will be South America and the Middle East, where growth will be at CAGRs of 16.2% and 14.3% respectively, during 2020-2025. These will be followed by Africa, and Eastern Europe where the markets are expected to grow at CAGRs of 12.5% and 11.6% respectively, during 2020-2025.

In addition to stockpiling of apparels from physical retail store shelves such as INDITEX, Uniqlo, and H&M, online ordering has also gone up. Due to lockdowns and travel restrictions around the world, people have less desire or need to purchase or wear much beyond casual clothing. As many companies announced the remote working option to their employees due to physical distancing restrictions, the market has witnessed a gradual increase in demand for work-from-home wear. Fashion retailers shifted their sales channel to online platforms focusing on new trends based on evolving consumer.

For example, according to the Facebook-BCG joint study report, around 90% of consumers purchased clothing online during the lockdown. During the pandemic, consumers find it safer to order apparels online rather than going outside to physical stores.

In the wake of the COVID-19 pandemic, apparel companies should respond to the crisis by collaborating and coordinating with other businesses with different functionalities, which limits the effect of a pandemic on the apparel market. Many companies began implementing various methods such as offering their products online and through wholesalers, finding new ways to promote their products through virtual trade shows. With increasing vaccination campaigns across the major countries in the European Union, the UK, the USA, India, and many other countries, future plans to fully open retail stores might increase the demand for apparel.

Apparel Global Market – By Type (Women’s Wear, Men’s Wear, Kids Wear), By Type Of Fiber (Man-Made Fibers, Cotton Fibers, Animal Based Fibers, Vegetable Based Fibers), By Distribution Channel (Online Sales, Offline Sales), And By Region, Opportunities And Strategies – Global Forecast To 2030 is one of a series of new reports from The Business Research Company that provide market overviews, analyze and forecast market size and growth for the whole market, segments and geographies, trends, drivers, restraints, leading competitors’ revenues, profiles and market shares in over 1,000 industry reports, covering over 2,500 market segments and 60 geographies.

The report also gives in-depth analysis of the impact of COVID-19 on the market. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. A highly experienced and expert team of analysts and modelers provides market analysis and forecasts. The reports identify top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here Is A List Of Similar Reports By The Business Research Company:

Ethical Fashion Market – Segmented By Product (Organic, Man-Made/Regenerated, Recycled, Natural), By Type (Fair Trade, Animal Cruelty, Eco-Friendly, Charitable Brands), By End-User (Men, Women, Kids) And By Region, Opportunities And Strategies – Global Forecast To 2030

Nanotechnology Clothing Global Market Report 2021: COVID 19 Growth And Change to 2030

Fashion E-Commerce Global Market Report 2021: COVID 19 Growth And Change to 2030

Interested to know more about The Business Research Company?

The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

The World’s Most Comprehensive Database

The Business Research Company’s flagship product, Global Market Model, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

The Business Research Company
                  
                  Europe: +44 207 1930 708
                  
                  Asia: +91 8897263534
                  
                  Americas: +1 315 623 0293
                  
                  Email: info@tbrc.info
                  
                  Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
                  
                  Follow us on Twitter: https://twitter.com/tbrc_info
                  
                  Check out our Blog: http://blog.tbrc.info/

Cannes Trend Talks 2021 Official Programme and invitation

Ster-Kinekor, the official Cannes Lions representative in South Africa, along with Bizcommunity, online media partner to Ster-Kinekor, and The Creative Circle, invite you to book now for Cannes Trend Talks 2021 presented by Ann Nurock.

This year, the world’s most prestigious advertising festival, Cannes Lions went online for the first time and Ann Nurock and some of SA’s leading creatives, who were all category judges at this year’s festival, watched the talks by global thought leaders, analysed award-winning campaigns and identified key themes, to bring you their insights at Cannes Lions Trends Talks 2021 taking place online Thursday, 22 July.

Get the inside scoop on what’s really cutting through with audiences, as well as what’s steering the direction for local and global creative communities. – Cannes Lions

Find out about the 42% of consumers who make up the global Accenture study who said they would switch brands from providers who did not have relevant societal impact, and curated examples of the award-winning work with analysis. Ann Nurock presents her annual case studies, which show how creativity continues to be a driver in identifying and addressing some of the world’s most urgent problems.

“The work this year was really fresh, not because it was new, but because it was more human. Work that solved problems delivered a better ROI,” Ann Nurock, senior partner: Relationship Audits Management, industry advocate and Cannes Lions reporter.

Book out 2pm-6pm 22 July 2021 in your calendar for this immersion session virtually together with your peers with Q&A sessions after each speaker.

Cannes Lions Trends Talks 2021 Programme

• 2pm: Welcome by MC Neo Mashigo, presents Creative Circle rankings
• 2.20pm: Ann Nurock “The year that changed everything” trends presentation
• 3.20–3.30pm: Q&A
• 3.30pm: Break, awards-winning reels
• 3.40pm: Panel discussions:  
  • Brett Morris (Film Lions juror)
  • Steph van Niekerk (Industry Craft Lions)
  • Lufuno Mavhungu (Radio and Audio Lions juror)
• 4.15pm: Break, award-winning reels
• 4.35pm: Neo Mashigo hosts panellists:  
  • Nkgabiseng Motau (Print & Publishing Lions juror)
  • Tanya Schreuder (Media Lions juror)
  • Bryan Habana (Entertainment Lions for Sport jurors)
• 6pm: Event to conclude

Book now for this annual industry highlight proudly brought to you by Ster-Kinekor, official SA Cannes Lions representatives, Creative Circle and Bizcommunity (supported by the Loeries).

Save the date and book now: 22 July 2021 | 2pm | R150 per ticket Secure your ticket by email: cannestrendtalks@sterkinekor.com

For more:

More info: Cannes Lions special section
Distributed by APO Group on behalf of Bizcommunity.

Take The Whip Roller Derby TV Show Launches Its First Crowdfunding Campaign on Indiegogo

MELBOURNE, USA, July 15, 2021 /EINPresswire.com/ — The creator of the roller derby TV show, Take the Whip, is happy to announce the launch of a crowdfunding campaign intended to raise funds for the pilot episode of this unique drama series.

Based on real-life events, Take the Whip offers a funny, moving, and wry look at life as a roller derby player. Created by Jacquelynn Wolfheart, Take the Whip is a new TV drama series that follows a group of women fighting to make it in the world of roller derby. As bonds form between the show’s protagonists, Take the Whip explores the hugely diverse characters who are drawn to roller derby, and how they came to be where they are.

In advance of the production of the pilot episode of Take the Whip, the show’s creator has launched an Indiegogo crowdfunding campaign to raise funds for the pilot episode. Crowdfunding has been chosen as the ideal method of raising capital in order to keep the show as true to life as the creator intended. By raising money on Indiegogo, it’s hoped that Take the Whip’s pilot episode will be as much of a showcase for the real people who play roller derby as it is for the sport itself.

“We’ve considered working with well-known production studios, and we understand the important role they’re going to play when it comes to getting Take the Whip on TV,” a spokesperson from the production team behind Take the Whip said. “But for the pilot episode, we want to make sure we shoot our script the way it’s meant to be, with real roller derby players, telling real stories. That’s why we’re hoping to fund at least 10% of the production budget for this episode ourselves: so that we can keep creative control over the project.”

The Indiegogo campaign is seeking to raise $300,000 in total to fund the show’s pilot episode, with most of this money going towards production, editing, and casting. Backers can net themselves prizes for bigger donations, ranging from a signed copy of the script for the pilot episode to producer credits and an equity stake in the show.

To donate to the crowdfunding campaign for Take the Whip’s pilot episode and help make this TV show a reality, backers can donate today on Indiegogo here (https://www.indiegogo.com/projects/take-the-whip-pilot-episode#/). The campaign runs until the end of August, with the production of the Take the Whip pilot episode planned to begin

Dr Jacquelynn Wolfheart PhD
Take The Whip
TakeTheWhipSeries@gmail.com
Visit us on social media:
Twitter